Article Information
History
- February 16, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Julia Telser1,2,3,
- Kirsten Grossmann1,3,
- Ornella C Weideli1,4,
- Dorothea Hillmann2,
- Stefanie Aeschbacher1,9,
- Niklas Wohlwend3,7,
- Laura Velez1,8,
- Jens Kuhle6,
- Aleksandra Maleska6,
- Pascal Benkert6,
- Corina Risch1,2,
- David Conen10,
- Martin Risch1,2,5 and
- Lorenz Risch1,2,3,*
- 1Dr Risch Medical Laboratory, Vaduz, Liechtenstein
- 2Dr Risch Medical Laboratory, Buchs, Switzerland
- 3Private University in the Principality of Liechtenstein (UFL), Triesen, Principality of Liechtenstein
- 4Soneva Fushi, Boduthakurufaanu Magu, Male 20077, Maldives
- 5Division of Laboratory Medicine, Kantonsspital Graubünden, Chur, Switzerland
- 6Neurologic Clinic and Policlinic, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel, University of Basel, Basel, Switzerland
- 7University of Bern, Bern, Switzerland
- 8University of St. Gallen, St. Gallen, Switzerland
- 9Department of Cardiology, University Hospital of Basel, Basel, Switzerland
- 10Population Health Research Institute, McMaster University, Hamilton, Canada
- ↵*Corresponding author Address for correspondence: lorenz.risch{at}ufl.li
Posted February 16, 2023.
The role of serum brain injury biomarkers in individuals with a mild-to-moderate COVID infection and Long-COVID - results from the prospective population-based COVI-GAPP study
